Research Paper Volume 15, Issue 17 pp 8744—8769
Comprehensive analysis and experimental validation reveal elevated CLCN4 is a promising biomarker in endometrial cancer
Figure 8. Correlation of CLCN4 expression with microsatellite instability (MSI) and tumor mutational burden (TMB). (A) Correlation between ClCN4 and MSI. (B) Correlation between CLCN4 and TMB.